CCR5 interactions with the variable 3 loop of gp120

被引:0
|
作者
Kelby B. Napier
Zi-xuan Wang
Stephen C. Peiper
John O. Trent
机构
[1] University of Louisville,Department of Biochemistry and Molecular Biology
[2] Medical College of Georgia,Department of Pathology and Institute of Molecular Medicine and Genetics
[3] University of Louisville,J. G. Brown Modeling Facility, Brown Cancer Center
[4] University of Louisville,Department of Medicine
来源
关键词
HIV-1; CCR5; Molecular modeling; gp120; V3 loop;
D O I
暂无
中图分类号
学科分类号
摘要
The G-protein coupled receptor CCR5 functions pathologically as the primary co-receptor for macrophage tropic (R5) strains of HIV-1. The interactions responsible for co-receptor activity are unknown. Molecular-dynamics simulations of the extracellular and adjacent transmembrane domains of CCR5 were performed with explicit solvation utilizing a rhodopsin-based homology model. The functional unit of co-receptor binding was constructed via docking and molecular-dynamics simulation of CCR5 and the variable 3 loop of gp120, which is a dominant determinant of co-receptor utilization. The variable 3 loop was demonstrated to interact primarily with the amino terminus and the second extracellular loop of CCR5, providing novel structural information regarding the co-receptor-binding site. Alanine mutants that alter chemokine binding and co-receptor activity were examined. Molecular-dynamics simulations with and without the variable 3 loop of gp120 were able to rationalize the activities of these mutants successfully, providing support for the proposed model. Based on these results, the global complex of CCR5, gp120 including the V3 loop and CD4, was investigated. The utilization of computational analysis, in combination with molecular biological data, provides a powerful approach for understanding the use of CCR5 as a co-receptor by HIV-1.
引用
收藏
页码:29 / 41
页数:12
相关论文
共 50 条
  • [21] HIV gp120 interactions with coreceptors: Insights from studies with CCR5-based peptides
    Berger, Edward A.
    Alkhatib, Ghalib
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2007, 12 (09) : 403 - 407
  • [22] MODULATORY EFFECTS OF THE NOVEL CCR5 ANTAGONIST MARAVIROC ON MICROGLIAL PRO-INFLAMMATORY ACTIVATION ELICITED BY GP120
    Lisi, L.
    Navarra, P.
    Dello Russo, C.
    INFECTION, 2011, 39 : S35 - S35
  • [23] Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 Target Different Sequence Determinants on CCR5
    Tam, Kayan
    Schultz, Megan
    Reyes-Robles, Tamara
    Vanwalscappel, Benedicte
    Horton, Joshua
    Alonzo, Francis, III
    Wu, Beili
    Landau, Nathaniel R.
    Torres, Victor J.
    MBIO, 2016, 7 (06):
  • [24] MONITORING THE INTERACTION BETWEEN THE HIV-1 GP120 V3 LOOP AND THE N-TERMINAL CCR5 PEPTIDE CONSTRUCTS THROUGH NMR SPECTROSCOPY
    Galanakis, P.
    Spyroulias, G. A.
    Morikis, D.
    Rizos, A.
    Krambovitis, E.
    JOURNAL OF PEPTIDE SCIENCE, 2004, 10 : 271 - 271
  • [25] NMR conformational studies of the interaction between the V3 loop of HIV-1 coat glycoprotein gp120 and chemokine receptor CCR5, at peptide level
    Galanakis, PA
    Kandias, N
    Spyroulias, GA
    Sioumpara, M
    Morikis, D
    Rizos, A
    Krambovitis, E
    FEBS JOURNAL, 2005, 272 : 548 - 548
  • [26] Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120
    Choe, H
    Li, WH
    Wright, PL
    Vasilieva, N
    Venturi, M
    Huang, CC
    Grundner, C
    Dorfman, T
    Zwick, MB
    Wang, LP
    Rosenberg, ES
    Kwong, PD
    Burton, DR
    Robinson, JE
    Sodroski, JG
    Farzan, M
    CELL, 2003, 114 (02) : 161 - 170
  • [27] Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction
    David J Grainger
    Andrew ML Lever
    Retrovirology, 2
  • [28] Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction
    Grainger, DJ
    Lever, AML
    RETROVIROLOGY, 2005, 2 (1)
  • [29] Gp120 V3-dependent impairment of R5 HIV-1 infectivity due to virion-incorporated CCR5
    Monde, Kazuaki
    Maeda, Yosuke
    Tanaka, Yuetsu
    Harada, Shinji
    Yusa, Keisuke
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (51) : 36923 - 36932
  • [30] Analysis of the HIV-1 gp120 V3 loop at screening for treatment-experienced patients in the MOTIVATE studies who failed with CCR5 tropic virus
    Lewis, M.
    Simpson, P.
    Jubb, B.
    Craig, C.
    Valdez, H.
    Westby, M.
    ANTIVIRAL THERAPY, 2010, 15 : A76 - A76